US 10889587
Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use
granted A61KA61K45/06A61P
Quick answer
US patent 10889587 (Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use) held by SPERO THERAPEUTICS, INC. expires Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SPERO THERAPEUTICS, INC.
- Grant date
- Tue Jan 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K45/06, A61P, A61P31/04